Concern Over Adverse Events in Prostate Cancer Trial Concern Over Adverse Events in Prostate Cancer Trial

A phase 3 trial investigating the addition of radium-223 to abiraterone acetate plus steroid has been stopped after reports of fractures and deaths.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news